FDA clears Abbott's cholesterol medicine TriLipix

Abbott Laboratories secured FDA clearance to market TriLipix, a cholesterol drug that can be used alone or with statins to manage lipid problems. TriLipix contains the active ingredient in the firm's TriCor, a blockbuster cholesterol medication that will start losing patent protection in 2011.

View Full Article in:

Wall Street Journal, The · Daily Herald (Arlington Heights, Ill.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT